David C Montefiori, Ph.D.
Duke University
H-index: 152
North America-United States
Top articles of David C Montefiori, Ph.D.
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques | Cell | Kevin O Saunders James Counts Bhishem Thakur Victoria Stalls Robert Edwards | 2024/1/4 |
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine | Oncology | Elrazi Awadelkarim Hamid Ali Ibrahim Khamees Awni Alshurafa Hanaa Qasim Mohammad Abdullah Abu-Tineh | 2022/7/26 |
SARS-CoV-2 Omicron sub-variant Neutralization following a primary vaccine series of NVX-CoV2373 and BNT162b2 monovalent booster vaccine | Open Forum Infectious Diseases | Tara M Babu Xiaoying Shen R Scott McClelland Zijun Wang Stacy Selke | 2024/1/3 |
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study | Scientific Reports | Thanyawee Puthanakit Eakachai Prompetchara Sivaporn Gatechompol Chutitorn Ketloy Arunee Thitithanyanont | 2024/1/29 |
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction | Cell Host & Microbe | Kevin Wiehe Kevin O Saunders Victoria Stalls Derek W Cain Sravani Venkatayogi | 2024/4/25 |
Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA. 2.86 | bioRxiv | Sam Turner Gayatri Amirthalingam Dalan Bailey Dan H Barouch Kevin R Bewley | 2024 |
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features | Proceedings of the National Academy of Sciences | Michal Juraska Hongjun Bai Allan C deCamp Craig A Magaret Li Li | 2024/1/23 |
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials | nature communications | Daniel B Reeves Bryan T Mayer Allan C deCamp Yunda Huang Bo Zhang | 2024/3/22 |
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals | medRxiv | Nathan B Erdmann Wilton B Williams Stephen R Walsh Nicole Grunenberg Paul T Edlefsen | 2024 |
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines | Journal of Virology | Matthew J Vukovich Nagarajan Raju Prudence Kgagudi Nelia P Manamela Alexandra A Abu-Shmais | 2024/1/23 |
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines | The Journal of Infectious Diseases | Spyros Chalkias Nichole McGhee Jordan L Whatley Brandon Essink Adam Brosz | 2024/2/13 |
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087) | medRxiv | Stephen R Walsh Cynthia L Gay Shelly T Karuna Ollivier Hyrien Timothy Skalland | 2024 |
Contralateral second dose improves antibody responses to a two-dose mRNA vaccination regimen | The Journal of Clinical Investigation | Sedigheh Fazli Archana Thomas Abram E Estrada Hiro AP Ross David Xthona Lee | 2024/1/16 |
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition | bioRxiv | Qianyi E Zhang Jared Lindenberger Ruth J Parsons Bhishem Thakur Rob Parks | 2024/2/13 |
A germline-targeting chimpanzee SIV envelope glycoprotein elicits a new class of V2-apex directed cross-neutralizing antibodies | Mbio | Frederic Bibollet-Ruche Ronnie M Russell Wenge Ding Weimin Liu Yingying Li | 2023/2/28 |
Immunogenicity of the BA. 1 and BA. 4/BA. 5 SARS-CoV-2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial | medRxiv | Angela R Branche Nadine G Rouphael Cecilia Losada Lindsey R Baden Evan J Anderson | 2023/3/31 |
Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial | Research Square | Angela Branche Nadine Rouphael David Diemert Ann Falsey Cecilia Losada | 2023/5/5 |
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition | EBioMedicine | Kelly E Seaton Yunda Huang Shelly Karuna Jack R Heptinstall Caroline Brackett | 2023/7/1 |
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19 | Nature Communications | Spyros Chalkias Charles Harper Keith Vrbicky Stephen R Walsh Brandon Essink | 2023/8/23 |
Mutational basis of serum cross-neutralization profiles elicited by infection or vaccination with SARS-CoV-2 variants | bioRxiv | Kshitij Wagh Xiaoying Shen James Theiler Bethany Girard Jean-Claude Marshall | 2023 |
